# A Randomized, Open-label, Two-arm, Two-period, Multiple-dose, Study to Evaluate Pharmacokinetic Drug-drug Interaction, Safety and Tolerability of UIC202601 and UIC202602 in Healthy Volunteers

> **NCT07682948** · PHASE1 · RECRUITING · sponsor: **Korea United Pharm. Inc.** · enrollment: 36 (estimated)

## Conditions studied

- Hypertension
- Dyslipidemia

## Interventions

- **DRUG:** Investigational Product 1
- **DRUG:** Investigational Product 2
- **DRUG:** Investigational Product 1 + Investigational Product 2

## Key facts

- **NCT ID:** NCT07682948
- **Lead sponsor:** Korea United Pharm. Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-07-01
- **Primary completion:** 2026-09
- **Final completion:** 2026-09
- **Target enrollment:** 36 (ESTIMATED)
- **Last updated:** 2026-07-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07682948

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07682948, "A Randomized, Open-label, Two-arm, Two-period, Multiple-dose, Study to Evaluate Pharmacokinetic Drug-drug Interaction, Safety and Tolerability of UIC202601 and UIC202602 in Healthy Volunteers". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07682948. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*